Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide
US8962553B2 · kind B2 · utility
5Cited by
20References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2012 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Nov 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit improved pharmacokinetic and biological activity in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.